The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Chicago

About this trial

The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.

Eligibility criteria

Qualifiers

Receiving ongoing, out-patient care at the University of Chicago Medical Center under the routine care of a physician participating in this trial

Life expectancy of at least 3 years

Must be 18 years or older

Must be taking at least 1 (but not more than 6) prescription medications at the time of enrollment OR be 65 years or older OR be reasonably expected to require the use of a prescription medication within the next 5 years

Disqualifiers

Patients with acute or chronic disease which could be reasonably expected to result in the patient's death within the next 3 years.

Patients who have undergone, or are being actively considered for, liver or kidney transplantation.

Inability to understand and give informed consent to participate.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,200 Participants
are grouped into 1 trial group

Sponsors and collaborators